B-Cell Prolymphocytic Leukemia, also known as b-pll, is related to prolymphocytic leukemia and lymphoproliferative syndrome. An important gene associated with B-Cell Prolymphocytic Leukemia is CD5 (CD5 Molecule), and among its related pathways/superpathways are Innate Immune System and PI3K-Akt signaling pathway. The drugs Ofatumumab and Obinutuzumab have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and spleen, and related phenotypes are cellular and normal